W. Bradford Smith
2019 - Homology Medicines
In 2019, W. Bradford Smith earned a total compensation of $1.9M as Chief Financial Officer at Homology Medicines.
Compensation breakdown
| Non-Equity Incentive Plan | $153,680 |
|---|---|
| Option Awards | $1,307,536 |
| Salary | $384,200 |
| Other | $14,880 |
| Total | $1,860,296 |
Smith received $1.3M in option awards, accounting for 70% of the total pay in 2019.
Smith also received $153.7K in non-equity incentive plan, $384.2K in salary and $14.9K in other compensation.
Rankings
In 2019, W. Bradford Smith's compensation ranked 6,303rd out of 13,971 executives tracked by ExecPay. In other words, Smith earned more than 54.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,303 out of 13,971 | 55th |
Division Manufacturing | 2,370 out of 5,701 | 58th |
Major group Chemicals And Allied Products | 865 out of 2,200 | 61st |
Industry group Drugs | 732 out of 1,886 | 61st |
Industry Pharmaceutical Preparations | 541 out of 1,398 | 61st |
Source: SEC filing on April 28, 2020.
Smith's colleagues
We found two more compensation records of executives who worked with W. Bradford Smith at Homology Medicines in 2019.